Trump Presidency Impact On Biotechnology
11/29/2016 7:13:21 AM
In anticipation of the Trump presidency, GENETIC ENGINEERING & BIOTECHNOLOGY NEWS (GEN) surveyed 2,300 members of the global biotech community from industry and academia.
Of the 2,300 respondents, 47.70%, believe that the president-elect may not support NIH research funding. 19.74% said it would not make a difference, and 25.52% said Trump’s presidency would prove positive.
During the campaign, president-elect Trump hinted at possible support for higher NIH budgets, even as he has called for cutting federal spending: “We must make the commitment to invest in science, engineering, healthcare, and other areas that will make the lives of Americans better, safer, and more prosperous,” he has said.
comments powered by